ID   B72.3
AC   CVCL_G097
DR   CLO; CLO_0001828
DR   ABCD; ABCD_AJ341
DR   ATCC; HB-8108
DR   Wikidata; Q54752829
RX   Patent=US4522918;
RX   PubMed=3396010;
RX   PubMed=6789331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8108.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
RX   Patent=US4522918;
RA   Schlom, Jeffrey
RA   Colcher, David
RA   Nuti, Marianna
RA   Hand, Patricia H.
RA   Austin, Faye
RT   "Process for producing monoclonal antibodies reactive with human
RT   breast cancer.";
RL   Patent number US4522918, 11-Jun-1985.
//
RX   PubMed=3396010;
RA   Muraro, Raffaella
RA   Kuroki, Masahide
RA   Wunderlich, David
RA   Poole, Diane J.
RA   Colcher, David
RA   Thor, Ann
RA   Greiner, John William
RA   Simpson, Jean F.
RA   Molinolo, Alfredo Alberto
RA   Noguchi, Philip D.
RA   Schlom, Jeffrey
RT   "Generation and characterization of B72.3 second generation monoclonal
RT   antibodies reactive with the tumor-associated glycoprotein 72
RT   antigen.";
RL   Cancer Res. 48:4588-4596(1988).
//
RX   PubMed=6789331; DOI=10.1073/pnas.78.5.3199; PMCID=PMC319528;
RA   Colcher, David
RA   Hand, Patricia H.
RA   Nuti, Marianna
RA   Schlom, Jeffrey
RT   "A spectrum of monoclonal antibodies reactive with human mammary tumor
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:3199-3203(1981).
//